Breast Cancer Therapeutics in Major Developed Markets to 2021 - PowerPoint PPT Presentation

Loading...

PPT – Breast Cancer Therapeutics in Major Developed Markets to 2021 PowerPoint presentation | free to download - id: 800cad-YTY2O



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Breast Cancer Therapeutics in Major Developed Markets to 2021

Description:

Research Beam added a report on “Breast Cancer Therapeutics in Major Developed Markets to 2021” Enquiry about report: – PowerPoint PPT presentation

Number of Views:12

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Breast Cancer Therapeutics in Major Developed Markets to 2021


1
Breast Cancer Therapeutics in Major Developed
Markets to 2021 - Growth Driven by Rapid Uptake
of Premium Priced Biologics and Rising Incidence
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE 1 (503) 894-6022 E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview
  • Summary
  • Breast cancer, a malignant neoplasm, is the
    second most common cancer and the most common
    cancer in women worldwide, accounting for 16 of
    all female cancers, making the disease
    exceedingly prevalent. The number of women
    diagnosed with breast cancer has increased over
    the past few decades, but the number of deaths
    has declined due to earlier diagnosis and better
    treatment options.
  • Breast cancer treatment has been revolutionized
    in the past four decades, especially with
    increasing usage of targeted therapies. The
    marketed products landscape comprises a wide
    range of treatment options, including hormonal
    therapies, chemotherapies, combination therapies,
    and targeted therapies. Nevertheless, significant
    unmet need remains for products that can improve
    overall survival rate, time to disease
    progression, and overall response.
  • Read More At http//www.researchbeam.com/breast-c
    ancer-therapeutics-in-major-developed-to-2021-grow
    th-driven-by-rapid-uptake-of-premium-priced-biolog
    ics-and-rising-incidence-market

3


Table of Content
1 Table of Contents 4 1.1 List of Tables 7 1.2
List of Figures 7 2 Introduction 9 2.1 Disease
Introduction 9 2.2 Symptoms 10 3 Marketed
Products 24 3.1 Overview 24 3.2 Conclusion 39 4
Pipeline Products 40 4.1 Pipeline Products 40 4.2
Clinical Trials 44 5 Promising Drug Candidates
in Pipeline 54 5.1 Abemaciclib - Eli Lily 54 5.2
Buparlisib - Novartis 55
4


Table of Content
6 Market Forecast to 2021 70 6.1 Geographical
Markets 70 6.2 Global Market 70 7 Drivers and
Barriers for the Disease Market 82 7.1 Drivers
82 7.2 Barriers 82 8 Deals and Strategic
Consolidations 84 8.1 Licensing Deals 84 8.2
Co-development Deals 90 9 Appendix 95 9.1 All
Pipeline Drugs by Phase of Development 95 9.2
Market Forecasts to 2021 152 Enquire At
http//www.researchbeam.com/breast-cancer-therapeu
tics-in-major-developed-to-2021-growth-driven-by-r
apid-uptake-of-premium-priced-biologics-and-rising
-incidence-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/breast-cancer-therapeu
tics-in-major-developed-to-2021-growth-driven-by-r
apid-uptake-of-premium-priced-biologics-and-rising
-incidence-market
Stay With Us
5933 NE Win Sivers Drive, 205, Portland, OR
97220 United States
TELEPHONE 1 (800) 910-6452 DIRECT 1 (503)
894-6022 E-MAIL sales_at_researchbeam.com
About PowerShow.com